SEC Form 3 · accession 0001193125-26-314787
Scribe Therapeutics, Inc. · SCTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
ELI LILLY & Co
10% Owner
Period of report
Jul 23, 2026
Accepted (ET)
Jul 23, 2026 · 9:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001853921
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 1,054,828 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
After giving effect to closing of the Issuer's initial public offering, the Reporting Person will cease to be a 10% Owner and, accordingly, will have no further Section 16 reporting obligations.